A practical reference on somatotroph: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-10-23. Anything still debated is marked as such rather than presented as settled.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The results showed that the model could be applied to MLC, but better predictive behavior was found with concentrations of surfactant below the CMC, sub-micellar. A final type of model based on molecular properties of a solute is a branch of quantitative structure-activity relationships (QSAR). QSAR studies attempt to correlate biological activity of drugs, or a class of drugs, with structures. The normally accepted means of uptake for a drug, or its metabolite, is through partitioning into lipid bilayers. The descriptor most often used in QSAR to determine the hydrophobicity of a compound is the octanol-water partition coefficient, log P. MLC provides an attractive and practical alternative to QSAR. When micelles are added to a mobile phase, many similarities exist between the micellar mobile phase/stationary phase and the biological membrane/water interface. In MLC, the stationary phase become modified by the adsorption of surfactant monomers which are structurally similar to the membranous hydrocarbon chains in the biological model. Additionally, the hydrophilic/hydrophobic interactions of the micelles are similar to that in the polar regions of a membrane. Thus, the development of quantitative structure-retention relationships (QRAR) has become widespread. Escuder-Gilabert et al. tested three different QRAR retention models on ionic compounds. Several classes of compounds were tested including catecholamines, local anesthetics, diuretics, and amino acids.
== External links == 16S rRNA, BioMineWiki Archived 2019-04-27 at the Wayback Machine Ribosomal Database Project II Archived 2020-08-19 at the Wayback Machine Ribosomal+RNA at the U.S. National Library of Medicine Medical Subject Headings (MeSH) SILVA rRNA Database Project (also includes Eukaryotes (18S) and LSU (23S/28S)) Video: rRNA: sequence, function & synthesis Halococcus morrhuae (archaebacterium) 5S rRNA
Liquid chromatography: Traditional chromatography columns were made of glass. Modern columns are mostly made of borosilicate glass, acrylic glass or stainless steel. To prevent the stationary phase from leaking out of the column interior a polymer, stainless steel or ceramic net is usually applied. Depending on the application material- and size-requirements may change. Gas chromatography (GC): Older columns were made of glass or metal packed with particles of a solid stationary phase. More recently, narrower diameter (capillary) columns have been made using fused silica coated on the inside with a film of the stationary phase material. GC columns are typically very long to take advantage of their low resistance to the flow of carrier gas. The materials of the column and the stationary phase must be suitable for GC operating temperatures, which may range as high as 300°C or more.
== Gel Formulation Ingredients == Formulation of topical gels is determined by important factors such as appearance, odor, spreadability, extrudability, viscosity, pH, texture, microbial contamination potential and bioavailability. The components of the vehicle should serve to make the skin surface more penetrable to the drug. Characteristics of the gel such as consistency and viscosity are affected by formulation design. Consistency and viscosity affect the adhesion and retention property of the gel, and are important in ensuring the gel is retained at the site of application and effective delivery of the drug. The ingredients in topical gel formulation can be broadly categorized into four types: gelator, solvent, drug, and excipients.
Sources: en.wikipedia.org
Di Prisco G, Casola L, Giuditta A (1967). "Purification and properties of a soluble reduced nicotinamide-adenine dinucleotide (phosphate) dehydrogenase from the hepatopancreas of Octopus vulgaris". Biochem. J. 105 (2): 455–60. doi:10.1042/bj1050455. PMC 1198331. PMID 4171422. GIUDITTA A, STRECKER HJ (1961). "Purification and some properties of a brain diaphorase". Biochim. Biophys. Acta. 48: 10–9. doi:10.1016/0006-3002(61)90509-1. PMID 13705804. MAERKI F, MARTIUS C (1960). "[Vitamin K reductase, preparation and properties.]". Biochem. Z. 333: 111–35. PMID 13765127. Misaka E, Nakanishi K. "Studies on menadione reductase of bakers' yeast. I. Purification, crystallization and some properties". J. Biochem. Tokyo: 465–471. WOSILAIT WD (1960). "The reduction of vitamin K1 by an enzyme from dog liver". J. Biol. Chem. 235 (4): 1196–201. doi:10.1016/S0021-9258(18)69504-3. PMID 13846011. Sparla F, Tedeschi G, Trost P (1996). "NAD(P)H:(Quinone-Acceptor) Oxidoreductase of Tobacco Leaves Is a Flavin Mononucleotide-Containing Flavoenzyme". Plant Physiol. 112 (1): 249–258. doi:10.1104/pp.112.1.249. PMC 157943. PMID 12226388. Braun M, Bungert S, Friedrich T (1998). "Characterization of the overproduced NADH dehydrogenase fragment of the NADH:ubiquinone oxidoreductase (complex I) from Escherichia coli". Biochemistry. 37 (7): 1861–7. doi:10.1021/bi971176p. PMID 9485311. Jaiswal AK (2000). "Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases". Arch. Biochem. Biophys. 375 (1): 62–8. doi:10.1006/abbi.1999.1650. PMID 10683249.
For centuries, the Danes and Saxons had regarded each other as kindred peoples, sharing the same belief in the Germanic pantheon and frequently intermarrying, especially among the elite. Thus, the defeated Saxon warleader Widukind sought refuge with his father-in-law, Danish king Sigfred. The Royal Frankish Annals mentions that Widukind received substantial aid from Sigfred, though the exact nature of this aid is not explicitly stated. However, the chronicles do note that Sigfred and Charlemagne brokered a peace agreement some years later, indicating that Sigfred, upon hearing Widukind's plea, may have mustered his army and joined the war on the side of the Saxons. In response to the Danes' involvement in the war, Charlemagne seems to have recruited the Obotrites by promising them the Saxon portion of Holstein. This alliance with Charlemagne shifted the balance of power in the region. In 782, after another defeat of the Saxons, Charlemagne ordered the mass execution of 4,500 Saxons, an atrocity that became known as the Massacre of Verden. Following this brutal act, Charlemagne was nicknamed the "Butcher of Saxons" or "Saxonslaughterer." In 796, despite Saxony being fully under Frankish rule, the Saxons rose once more, supported by the Danes. The rebellion was triggered by the forced conscription of Saxons for the Frankish wars against the Avars. Moreover, Charlemagne, in alliance with the Obotrites, planned to subjugate the Danes, now led by King Gudfred Sigfredson. However, Gudfred struck first.
Customers can go to many places for wings and beer, but it is our Hooters Girls who make our concept unique. Hooters offers its customers the look of the "All American Cheerleader, Surfer, Girl Next Door." Female employees are required to sign that they "acknowledge and affirm" the following:
Disinfecting uses a chemical product, which is a process that kills the germs on the surfaces. In most situations, regular cleaning of surfaces with soap and detergent, not necessarily disinfecting those surfaces, is enough to reduce the risk of COVID-19 spread. Disinfection is only recommended in indoor settings — schools and homes — where there has been a suspected or confirmed case of COVID-19 within the last 24 hours. In most situations, regular cleaning of surfaces with soap and detergent, not necessarily disinfecting those surfaces, is enough to reduce the risk of COVID-19 spread." The CDC issued a special report "Knowledge and Practices Regarding Safe Household Cleaning and Disinfection for COVID-19 Prevention" due to the increased number of calls to poison centers regarding exposures to cleaners and disinfectants since the onset of the COVID-19 pandemic, concluding that "Public messaging should continue to emphasize evidence-based, safe cleaning and disinfection practices to prevent SARS-CoV-2 transmission in households, including hand hygiene and cleaning and disinfection of high-touch surfaces." CDC provides a Guideline for Disinfection and Sterilization in Healthcare Facilities.
=== Vitamin D deficiency === Vitamin D in the kidney assists in the absorption of calcium in the blood. Some individuals may be vitamin D deficient, which prevents them from retaining calcium. While their parathyroid gland is functional, it senses a very low level of calcium in the blood and constantly secretes hormone, increasing PTH levels.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.